Janumet Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers(Fed)
Condition:   Healthy Interventions:   Combination Product: Janumet XR tablet 100/1000 mg;   Combination Product: GLH1SM tablet 100/1000 mg Sponsor:   GL Pharm Tech Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2019 Category: Research Source Type: clinical trials

Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers
Condition:   Healthy Interventions:   Combination Product: Janumet XR tablet 100/1000 mg;   Combination Product: GLH1SM tablet 100/1000 mg Sponsor:   GL Pharm Tech Corporation Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials